|
5th International AIDS Society Conference on HIV Pathogenesis and TreatmentCape Town - July 19 - 22, 2009 |
LOWER RISK OF HIV INFECTION AMONG CIRCUMCISED MSM: RESULTS FROM THE SOWETO MEN'S STUDY
IAS Conf HIV Pathog Treat 2009 Jul 19-22;5th: Abstract No. MOPDC105
T. Lane
1, H.F. Raymond2, S. Dladla3, J. Rasethe3, H. Struthers3, W. McFarland2, J. McIntyre3
1University of California San Francisco, Center for AIDS Prevention Studies, San Francisco, United States, 2San Francisco Department of Public Health, San Francisco, United States, 3Perinatal HIV Research Unit (PHRU), Johannesburg, South Africa
BACKGROUND: While results of clinical trials have shown that circumcision reduces men's risk of HIV infection through vaginal sex, the effect of circumcision on homosexual transmission through anal intercourse (AI) is less well understood. A recent meta-analysis of available observational data found insufficient evidence of a protective effect with men who have sex with men (MSM), noting that data from high-prevalence, resource-challenged settings are lacking. The Soweto Men's Study explored the association between insertive AI and HIV infection in a peri-urban South African MSM community.
METHODS: 378 MSM from Soweto were recruited via respondent-driven sampling (RDS). Participants reported their sexual behavior with their last five partners, including positioning during AI (insertive, receptive, or both) with men. Circumcision status was self-reported, and HIV status was determined though rapid antibody testing. All results have been adjusted for network size and recruitment patterns as recommended by RDS methodology, and are reported with 95% confidence intervals (CI).
RESULTS: HIV prevalence was 13.2% (12.4%-13.9%), and circumcision prevalence was 36.4% (30.0%-44.8%). Exclusive insertive AI (IAI) was reported by 76.4% (75.4%-77.3%); 88.1% (87.1%-89.1%) of these also reported female sexual partners. In multivariable analysis, the odds of infection among uncircumcised MSM reporting exclusive IAI with male partners was significantly higher than among insertive circumcised MSM (AOR 4.5, 95% CI 3.1-6.7).
CONCLUSIONS: Circumcision may be effective at reducing HIV transmission between men in high prevalence settings such as Soweto where MSM practice a high degree of sexual role segregation. It may be feasible to conduct a randomized controlled trial of circumcision among MSM in such communities. The acceptability and ethical implications of male circumcision in MSM populations must be assessed prior to initiating clinical trials.
Download PDF of this abstract.
Download Power Point Presentation.
2009-07-22
MOPDC105
Male Circumcision - Ongoing Research
Copyright © 2009 - International AIDS Society (IAS). All information and content relating to the abstracts from the 5th International AIDS Society Conference on HIV Pathogenesis and Treatment, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you. Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.